Crexont 70mg + 280mg (Carbidopa + Levodopa Capsule) 70mg + 280mg

Crexont 70mg + 280mg is primarily used to manage symptoms of Parkinson's disease and Parkinson-like conditions. Parkinson's disease is characterized by a deficiency of dopamine in the brain, leading to symptoms such as shakiness, stiffness, and difficulty moving. Crexont helps to alleviate these symptoms by increasing dopamine levels in the brain.

• Parkinson's disease: Helps control movement and reduce symptoms such as shakiness, stiffness, and difficulty moving.
• Parkinsonian syndrome: Used to treat symptoms caused by conditions similar to Parkinson's disease, such as those resulting from encephalitis or carbon monoxide poisoning.

• Levodopa is converted into dopamine in the brain, which helps to control movement and alleviate symptoms of Parkinson's disease. Carbidopa inhibits the peripheral aromatic L-amino acid decarboxylase, which prevents the breakdown of levodopa in the bloodstream. This allows more levodopa to enter the brain, increasing its effectiveness and reducing peripheral side effects such as nausea and vomiting.

Crexont 70mg + 280mg may cause various side effects, ranging from common to serious. It is important to be aware of these potential effects and consult a healthcare professional if they occur.

Common Side Effects

• Nausea: Feeling sick to your stomach.
• Dizziness: Feeling lightheaded or unsteady.
• Headache: Pain or discomfort in the head.
• Insomnia: Difficulty falling or staying asleep.
• Dry mouth: A sensation of dryness in the mouth.
• Constipation: Difficulty passing stools.

Serious or Rare Side Effects

• Neuroleptic malignant syndrome: Symptoms include high fever, stiff muscles, confusion, and irregular heartbeat.
• Hallucinations: Seeing, hearing, or feeling things that are not real.
• Dyskinesia: Involuntary movements such as twitching or jerking.
• Orthostatic hypotension: A sudden drop in blood pressure upon standing, leading to dizziness or fainting.
• Psychiatric symptoms: Mood changes, depression, or anxiety.

Crexont 70mg + 280mg should be used with caution and under the supervision of a healthcare professional. Certain precautions and warnings should be observed to ensure safe and effective use.

• Consult a healthcare professional: Before starting Crexont, discuss your medical history and any other medications you are taking.
• Avoid alcohol: Do not consume alcohol while taking Crexont, as it may increase the risk of side effects.
• Driving and operating machinery: Crexont may cause dizziness or drowsiness; avoid activities that require alertness until you know how the medication affects you.
• Pregnancy and breastfeeding: Consult your doctor before using Crexont if you are pregnant, planning to become pregnant, or breastfeeding.
• Store at room temperature: Keep Crexont in a closed container at room temperature, away from heat, moisture, and direct light. Keep out of the reach of children.

Crexont 70mg + 280mg may interact with other medications, potentially altering its effectiveness or increasing the risk of side effects. It is important to be aware of these interactions and consult a healthcare professional.

Major Interactions (Avoid)

• Non-selective MAO inhibitors: Avoid taking Crexont with non-selective MAO inhibitors such as phenelzine or tranylcypromine, as it may lead to dangerous interactions.
• Iron supplements: Avoid taking iron supplements with Crexont, as iron can interfere with the absorption of levodopa.
• High-protein diets: High-protein diets can interfere with the absorption of levodopa, reducing its effectiveness.

Moderate Interactions (Monitor Closely)

• Antihypertensives: Crexont may interact with antihypertensive medications, leading to changes in blood pressure.
• Antipsychotics: Antipsychotic medications may reduce the effectiveness of Crexont.
• Sedatives: Sedatives may increase the risk of drowsiness and dizziness when taken with Crexont.